Receptor-mediated tumor targeting has received major attention in the field of cancer drug
delivery in the past few years. Receptors, as molecular target has opened new opportunities …

CG‐rich duplex containing prostate‐specific membrane antigen (PSMA) aptamer‐
conjugated thermally cross‐linked superparamagnetic iron oxide nanoparticles (TCL …

As proteomics technologies develop, increasing number of membrane-associated proteins
specific for cancer cells are being discovered. These proteins are of great interest …

Context.—Prostate-specific membrane antigen (PSMA) is expressed in endothelium of
vessels in malignant solid tumors but not in normal vessels. Objective.—To examine …

Prostate-specific membrane antigen (PSMA), a well-known biomarker of prostate cancer,
has also been found to be highly expressed in the neovasculature of multiple non-prostatic …

Prostate-specific membrane antigen (PSMA), a type II transmembrane protein, has been
becoming an active target for imaging and therapeutic applications for prostate cancer …

β-Citrylglutamate (BCG), a compound present in adult testis and in the CNS during the pre-
and perinatal periods is synthesized by an intracellular enzyme encoded by the RIMKLB …

As cancer treatment cost soar and the mantra for “personalized medicine” grows louder, we
will increasingly be searching for solutions to these diametrically opposed forces. In this …

The Prostate Specific Membrane Antigen (PSMA) is considered to be the most well
established target antigen in prostate cancer, since it is highly and specifically expressed at …

Glutamate carboxypeptidase II (GCPII; EC 3.4. 17.21), a Zn2+-dependent metalloprotease of
the M28 peptidase family, is a type II transmembrane glycoprotein. GCPII is also known as …